Rafferty Asset Management
COGT icon

Rafferty Asset Management’s Cogent Biosciences COGT Stock Holding History

Rafferty Asset Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.81M Buy
125,013
+13,919
+13% +$514K 0.02% 374
2025
Q4 		$3.95M Sell
111,094
-37,707
-25% -$1.06M 0.01% 498
2025
Q3 		$2.14M Buy
148,801
+57,139
+62% +$677K 0.01% 637
2025
Q2 		$658K Sell
91,662
-76,013
-45% -$421K ﹤0.01% 833
2025
Q1 		$1M Buy
167,675
+6,802
+4% +$53.3K ﹤0.01% 739
2024
Q4 		$1.25M Buy
160,873
+47,187
+42% +$470K ﹤0.01% 747
2024
Q3 		$1.23M Sell
113,686
-70,277
-38% -$684K ﹤0.01% 759
2024
Q2 		$1.55M Sell
183,963
-520,897
-74% -$3.95M 0.01% 707
2024
Q1 		$4.74M Buy
704,860
+416,189
+144% +$2.57M 0.02% 482
2023
Q4 		$1.7M Buy
288,671
+96,894
+51% +$742K 0.01% 715
2023
Q3 		$1.87M Sell
191,777
-14,366
-7% -$170K 0.01% 626
2023
Q2 		$2.44M Sell
206,143
-36,026
-15% -$413K 0.01% 590
2023
Q1 		$2.61M Sell
242,169
-81,718
-25% -$1.05M 0.02% 534
2022
Q4 		$3.74M Buy
323,887
+114,511
+55% +$1.42M 0.03% 439
2022
Q3 		$3.12M Buy
+209,376
New +$2.87M 0.03% 409

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Rafferty Asset Management's COGT Position: Q1 2026 in Review

Rafferty Asset Management increased its Cogent Biosciences (COGT) stake by 13% in Q1 2026, buying an estimated $514K and bringing the position to 125,013 shares worth $4.81M. The position accounts for 0.02% of the portfolio, ranked #374.

Rafferty Asset Management first reported a position in COGT in Q3 2022 and has held it in 15 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Rafferty Asset Management held 125,013 shares of Cogent Biosciences worth $4.81M as of Q1 2026.
  • Rafferty Asset Management bought 13,919 Cogent Biosciences shares in Q1 2026, an estimated $514K.
  • Cogent Biosciences made up 0.02% of Rafferty Asset Management's portfolio in Q1 2026, its #374 holding.
  • Rafferty Asset Management first reported a position in Cogent Biosciences in Q3 2022 and has held it in 15 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.